| 2024/08/16 17:31:02 | |
|---|---|
| Price | |
| 7.60 CHF | |
| Difference | 5.26% (0.38) |
General attributes
| ISIN | IT0004147952 |
| Symbol | NWRN |
| Exchange | SIX Swiss Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 151 EUR |
| Benchmark | FTSE MIB INDEX |
Market data
| Bid (Bid size) | 7.56 CHF (26) |
| Ask (Ask size) | 7.60 CHF (1,854) |
| Open | 7.20 CHF |
| High | 7.79 CHF |
| Low | 7.20 CHF |
| Close (prev. day) | 7.22 CHF |
| VWAP | 7.526403 CHF |
| Volume (pcs) | 78,592 |
| Trading volume | 591,515.08 |
| Number of trades | 278 |
| Last size | 81 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: NEWRON PHARMACEUTICALS SPA |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/08/12 |
|
Global Equity Ratings |
|
| 2024/07/24 |
|
Global Equity Ratings |
|
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/08/16 17:31:02 | |
|---|---|
| Price | |
| 7.60 CHF | |
| Difference | 5.26% (0.38) |
General attributes
| ISIN | IT0004147952 |
| Symbol | NWRN |
| Exchange | SIX Swiss Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 151 EUR |
| Benchmark | FTSE MIB INDEX |
Market data
| Bid (Bid size) | 7.56 CHF (26) |
| Ask (Ask size) | 7.60 CHF (1,854) |
| Open | 7.20 CHF |
| High | 7.79 CHF |
| Low | 7.20 CHF |
| Close (prev. day) | 7.22 CHF |
| VWAP | 7.526403 CHF |
| Volume (pcs) | 78,592 |
| Trading volume | 591,515.08 |
| Number of trades | 278 |
| Last size | 81 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -8.43% | +20.63% | +263.64% |
| Perf (abs.) | -0.70 | +1.30 | +5.51 |
| Beta | 1.29 | 1.25 | 0.43 |
| Volatility | 66.95 | 81.16 | 83.61 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 7.27 CHF (25,821) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 7.87 CHF (46,409) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 8.62 CHF (94,882) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 7.17 CHF (91,753) |
| YTD High | date | 11.45 CHF (2024/01/15) |
| YTD Low | date | 4.57 CHF (2024/01/03) |
| 52 Weeks High | date | 11.45 CHF (2024/01/15) |
| 52 Weeks Low | date | 4.09 CHF (2023/11/23) |
All listings for NEWRON PHARMACEUTICALS SPA
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Berlin | 2024/08/16 | 21:50 | 8.13 EUR | 0.00 | 19 |
| Duesseldorf | 2024/08/16 | 19:31 | 8.01 EUR | 0.00 | 4 |
| FINRA other OTC Issues | 2024/08/05 | 23:40 | 9.10 USD | 0.01 | 2 |
| Frankfurt | 2024/08/16 | 10:59 | 7.66 EUR | 0.00 | 2 |
| London Stock Exchange | 2024/04/29 | 09:33 | 7.1083 CHF | 0.01 | 1 |
| Munich | 2024/08/16 | 08:00 | 7.55 EUR | 0.00 | 2 |
| SIX Swiss Exchange | 2024/08/16 | 17:31 | 7.60 CHF | 0.59 | 278 |
| Tradegate | 2024/08/16 | 22:26 | 8.14 EUR | 0.04 | 23 |
| Xetra | 2024/08/16 | 17:35 | 8.17 EUR | 0.03 | 11 |
Company Logo
Contact Details
| NEWRON PHARMACEUTICALS SPA |
| - - |
| via Antonio Meucci 3 - 20091 Bresso |
| Telefon: +39-02-610-3461 |
| Fax: +39-02-610-34654 |
| E-mail: info@newron.com |
PDF Downloads
| Company report: NEWRON PHARMACEUTICALS SPA | |
Company Profile
Newron Pharmaceuticals SpA operates as a biopharmaceutical company. It focuses on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The firm's products include Xadago (safinamide), Evenamide (NW-3509) and Ralfinamide. The company was founded by Luca Benatti, Ruggero Fariello and Patricia Salvati in 1999 and is headquartered in Bresso, Italy. |
Members of Management Board
| Stefan Weber | Chairman of Managing Board |
| Dennis Dionne | Member of Executive Committee |
| Filippo Moriggia | Member of Executive Committee |
| Laura Faravelli | Member of Executive Committee |
| Ravi Anand | Member of Executive Committee |
| Roberto Galli | Member of Executive Committee |
Board of directors
| Ulrich Köstlin | Chairman of Supervisory Board |
| Luca Benatti | Member of Supervisory Board |
| Patrick Langlois | Member of Supervisory Board |
| Gillian Dines | Member of Supervisory Board |
| Margarita Chavez | Member of Supervisory Board |